Results

eNauka >  Rezultati >  Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, PlaceboControlled Phase II Study
Naziv: Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, PlaceboControlled Phase II Study
Autori: Hart Lowel L; Ferrarotto Renata; Andrić Zoran G  ; Beck Thaddeus J; Subramanian Janakiraman; Radosavljević Davorin Z  ; Zarić Bojan  ; Hanna Wahid T; Aljumaily Raid; Owonikoko Taofeek K;
Verhoeven Didier; Xiao Jie; Morris Shannon R; Antal Joyce M; Hussein Maen A;
Godina: 2020
Publikacija: ADVANCES IN THERAPY
ISSN: 0741-238X Advances in Therapy Pretraži identifikator
Izdavač: Springer
Tip rezultata: Naučni članak
Kolacija: vol. 38 br. 1 str. 350-365
DOI: 10.1007/s12325-020-01538-0
WoS-ID: 000582826000001
Scopus-ID: 2-s2.0-85094653176
PMID: 33123968
PMCID: PMC7854399
URI: https://zenodo.org/record/4709814
https://enauka.gov.rs/handle/123456789/597482
Projekat: url:https://static-content.springer.com/esm/art%3A10.1007%2Fs12325-020-01538-0/MediaObjects/12325_2020_1538_MOESM3_ESM.docx
pmcid:PMC7854399
doi:10.6084/ m9.figshare.13078844.
M-kategorija: 
21M21 - Vodeći međunarodni časopis kategorije M21

107
SCOPUSTM
51
PubMed CentralTM
41
OpenCitations
94
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.